The researchers compared the short-term tumor regression rate, side effects and quality of life improvement between the two groups. Efficacy was based on World Health Organization standards and included those patients who had a complete response (CR0% tumor disappearance) or a partial response (PRP% to 0.05).















Recent comments
3 years 34 weeks ago